Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Rodriguez

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 19, 2014
Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trialJennifer P Friedberg, Maria A Rodriguez, Michelle E Watsula, et al.
Cancer|November 1, 2008
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphomaMichael Wang, Luis Fayad, Fernando Cabanillas, et al.
Cancer|June 11, 2005
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimenApostolia-Maria Tsimberidou, Anas Younes, Jorge Romaguera, et al.
Cells|March 25, 2022
Failure Analysis of TEVG's II: Late Failure and Entering the Regeneration PathwayMaria A Rodriguez-Soto, Alejandra Riveros, Natalia Suarez Vargas, et al.
Leukemia & Lymphoma|October 26, 2011
Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up studyNicolas Batty, Fredrick B Hagemeister, Lei Feng, et al.
Leukemia & Lymphoma|September 8, 2011
Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomasNina Shah, Fernando Cabanillas, Bradley McIntyre, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Leukemia & Lymphoma|April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomasHoon K Lee, Richard B Wilder, Dan Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphomaChul S Ha, Fernando Cabanillas, Ming S Lee, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|November 19, 2014
Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trialJennifer P Friedberg, Maria A Rodriguez, Michelle E Watsula, et al.
Cancer|November 1, 2008
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphomaMichael Wang, Luis Fayad, Fernando Cabanillas, et al.
Cancer|June 11, 2005
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimenApostolia-Maria Tsimberidou, Anas Younes, Jorge Romaguera, et al.
Cells|March 25, 2022
Failure Analysis of TEVG's II: Late Failure and Entering the Regeneration PathwayMaria A Rodriguez-Soto, Alejandra Riveros, Natalia Suarez Vargas, et al.
Leukemia & Lymphoma|October 26, 2011
Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up studyNicolas Batty, Fredrick B Hagemeister, Lei Feng, et al.
Leukemia & Lymphoma|September 8, 2011
Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomasNina Shah, Fernando Cabanillas, Bradley McIntyre, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Leukemia & Lymphoma|April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomasHoon K Lee, Richard B Wilder, Dan Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphomaChul S Ha, Fernando Cabanillas, Ming S Lee, et al.
Pageof 8